Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
nm decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,101 - 1,120 results of 20,862 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.80s Refine Results
  1. 1101
    AngII decreases AdipoR1 expression in a c-Myc-dependent manner.

    AngII decreases AdipoR1 expression in a c-Myc-dependent manner. by Li Li (14993)

    Published 2013
    Save to List
    Saved in:
  2. 1102
    Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection.

    Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection. by Patricia A. Reis (109310)

    Published 2012
    Save to List
    Saved in:
  3. 1103
    A hypothetical model showing how PID1 promotes lipolysis by regulating the AKT/PDE3B/PKA/HSL signaling pathway, which is supported by the results of this study.

    A hypothetical model showing how PID1 promotes lipolysis by regulating the AKT/PDE3B/PKA/HSL signaling pathway, which is supported by the results of this study. by Chunyan Yin (5384525)

    Published 2019
    Save to List
    Saved in:
  4. 1104
    Flowchart of study selection.

    Flowchart of study selection. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  5. 1105
    Description of characteristics of included studies.

    Description of characteristics of included studies. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  6. 1106
    CaA decreases the CSCs-like properties of malignant HaCaT cells by p38.

    CaA decreases the CSCs-like properties of malignant HaCaT cells by p38. by Ye Yang (297214)

    Published 2013
    Save to List
    Saved in:
  7. 1107
    Ultra-performance liquid chromatography–electrospray ionization–mass spectrometry analysis of Moutan Cortex extract.

    Ultra-performance liquid chromatography–electrospray ionization–mass spectrometry analysis of Moutan Cortex extract. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1108
    Individual concentration-time profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats.

    Individual concentration-time profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1109
    PK profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats.

    PK profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1110
    Mean plasma concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats.

    Mean plasma concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1111
    Mean plasma concentration-time profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats.

    Mean plasma concentration-time profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1112
    Individual concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats.

    Individual concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1113
    Effects of MC treatment on symptoms and histological changes in DNBS-induced colitis rats.

    Effects of MC treatment on symptoms and histological changes in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1114
    Effects of MC treatment on protein expression in DNBS-induced colitis rats.

    Effects of MC treatment on protein expression in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1115
    PK profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats.

    PK profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1116
    Effect of remdesivir on invasive ventilation at 14 days.

    Effect of remdesivir on invasive ventilation at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  17. 1117
    Effect of remdesivir on all-cause mortality at 14 days.

    Effect of remdesivir on all-cause mortality at 14 days. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  18. 1118
    Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19.

    Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  19. 1119
    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19.

    Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:
  20. 1120
    Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19.

    Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

    Published 2020
    Save to List
    Saved in:

Search Tools: